Clinical trial
A Clinical Research Study Evaluating Ropinirole Treatment For Restless Legs…
NCT00225862 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00225862 |
|---|---|
| Title | A Clinical Research Study Evaluating Ropinirole Treatment For Restless Legs Syndrome (RLS) |
| Official title | A 12-week, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of Intermittent Dosing of Ropinirole in Patients With Restless Legs Syndrome (RLS) |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Restless Legs Syndrome |
| Intervention type | Drug |
| Interventions | ropinirole |
| Enrollment | 140 |
| Start date | Jan 1, 2005 |
| Completion | Dec 1, 2005 |
| First posted | Sep 26, 2005 |
| Last update posted | Sep 15, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: